Modulation of the myocardial response to ischemia

Laboratory Investigation

Volumn 78, Issue 11, 1998, Pages 1345-1373

  Buja, L Maximilian ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS; CARDIOVASCULAR RESPONSE; CELL DAMAGE; CELL DEATH; HEART MUSCLE ISCHEMIA; HEART MUSCLE METABOLISM; HEART VENTRICLE REMODELING; HIBERNATION; HUMAN; HUMAN CELL; PATHOGENESIS; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW;

ANIMALS; APOPTOSIS; HUMANS; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; MYOCARDIAL STUNNING; MYOCARDIUM; NECROSIS;

EID: 0344734113     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (345)

1. Agah R, Kirshenbaum LA, Abdellatif M, Truong LD, Chakraborty S, Michael LH, and Schneider MD (1997). Adenoviral delivery of E2F-1 directs cell cycle reentry and p53-independent apoptosis in postmitotic adult myocardium in vivo. J Clin Invest 100:2722-2728.
2. Alonso DR, Scheidt S, Post M, and Killip T (1973). Pathophysiology of cardiogenic shock: Quantification of myocardial necrosis, clinical, pathologic and electrocardiographic correlations. Circulation 48:588-596.
3. Anversa P and Kajstura J (1988). Myocyte cell death in the diseased heart (editorial). Circ Res 82:1231-1233.
4. Anversa P and Sonnenblick EH (1990). Ischemic cardiomyopathy: Pathophysiologic mechanisms. Prog Cardiovasc Dis 33:49-70.
5. Anversa P, Leri A, Beltrami CA, Guerra S, and Kajstura J (1998). Myocyte death and growth in the failing heart. Lab Invest 78:767-786.
6. Anversa P, Olivetti G, Leri A, Liu Y, and Kajstura J (1997). Myocyte cell death and ventricular remodeling. Curr Opin Nephrol Hypertens 6:169-176.
7. Armstrong SC, Hoover DB, Delacey MH, and Ganote CE (1996). Translocation of PKC, protein phosphatase inhibition and preconditioning of rabbit cardiomyocytes. J Mol Cell Cardiol 28:1479-1492.
8. Armstrong SC, Hoover DB, Shivell LC, and Ganote CE (1997a). Preconditioning of isolated rabbit cardiomyocytes: No evident separation of induction, memory and protection. J Mol Cell Cardiol 29:2285-2298.
9. Armstrong SC, Kao R, Gao W, Shivell LC, Downey JM, Honkanen RE, and Ganote CE (1997b). Comparison of in vitro preconditioning responses in isolated pig and rabbit cardiomyocytes: Effects of a protein phosphatase inhibitor, fostriecin. J Mol Cell Cardiol 29:3009-3024.
10. Auchampach JA, Rizvi A, Qiu Y, Tang XL, Maldonado C, Teschner S, and Bolli R (1997). Selective activation of A3 adenosine receptors with N6-(3-iodobenzyl)adenosine-5′-N-methyluronamide protects against myocardial stunning and infarction without hemodynamic changes in conscious rabbits. Circ Res 80:800-809.
11. Barbato R, Menabo R, Dainese P, Carafoli E, Schiaffino S, and Di Lisa F (1996). Binding of cytosolic proteins to myofibrils in ischemic rat hearts. Circ Res 78:821-828.
12. Bardales R, Hailey LS, Xie SS, Schaefer RF, and Hsu S-M (1996). In situ apoptosis assay for the detection of early acute myocardial infarction. Am J Pathol 149:821-829.
13. Bardales RH, Xie SS, and Hsu S-M (1997). In situ DNA fragmentation assay to detect apoptosis in paraffin tissue sections. Am J Clin Pathol 107:332-336.
14. Baroldi G (1975). Different types of myocardial necrosis in coronary heart disease: A pathophysiological review of their functional significance. Am Heart J 89:742-752.
15. Baroldi G, Falzi G, and Mariani F (1979). Sudden coronary death: A post-mortem study in 208 selected cases compared to 97 "control" subjects. Am Heart J 98:20-31.
16. Barry WH and Bridge JHB (1993). Intracellular calcium homeostasis in cardiac myocytes. Circ Res 87:1806-1815.
17. i in energy deprivation contracture. Circ Res 61:726-734.
18. Basso C, Thien G, Corrado D, Angelini A, Nava A, and Valente M (1996). Arrhythmogenic right ventricular cardiomyopathy: Dysplasia, dystrophy, or myocarditis? Circulation 94:983-991.
19. Baxter GF, Goodwin RW, Wright MJ, Kerac M, Heads RJ, and Yellon DM (1996a). Myocardial protection after monophosphoryl lipid A: Studies of delayed anti-ischaemic properties in rabbit heart. Br J Pharmacol 117:1685-1692.
20. Baxter GF, Heads RJ, and Yellon DM (1996b). Oxidative stress and the second window of protection after preconditioning. Circulation 94:2992-2993.
21. Baxter GF, Marber MS, Patel VC, and Yellon DM (1994). Adenosine receptor involvement in a delayed phase of myocardial protection 24 hours after ischemic preconditioning. Circulation 90:2993-3000.
22. Bennett MR, Evan GI, and Newby AC (1994). Deregulated expression of the c-myc oncogene abolishes inhibition of proliferation of rat vascular smooth muscle cells by serum reduction, interferon-gamma, heparin, and cyclic nucleotide analogues and induces apoptosis. Circ Res 74:525-536.
23. Bennett MR, Evan GI, and Schwartz SM (1995a). Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques. J Clin Invest 95:2266-2274.
24. Bennett MR, Gibson DF, Schwartz SM, and Tait JF (1995b). Binding and phagocytosis of apoptotic vascular smooth muscle cells is mediated in part by exposure of phosphatidylserine. Circ Res 77:1136-1142.
25. Bialik S, Geenen DL, Sasson IE, Cheng R, Horner JW, Evans SM, Lord EM, Koch CJ, and Kitsis RN (1997). Myocyte apoptosis during acute myocardial infarction in the mouse localizes to hypoxic regions but occurs independently of p53. J Clin Invest 100:1363-1372.
26. Bielawska AE, Shapiro JP, Jiang L, Melkonyan HS, Piot C, Wolfe CL, Tomei LD, Hannun Y, and Umansky SR (1997). Ceramide is involved in triggering of cardiomyocyte apoptosis induced by ischemia and reperfusion. Am J Pathol 151:1257-1263.
27. Birnbaum Y, Hale SL, and Kloner RA (1997). Ischemic preconditioning at a distance: Reduction of myocardial infarct size by partial reduction of blood supply combined with rapid stimulation of the gastrocnemius muscle in the rabbit. Circulation 96:1641-1646.
28. Björkerud S and Björkerud B (1996). Apoptosis is abundant in human atherosclerotic lesions, especially in inflammatory cells (macrophages and T cells), and may contribute to the accumulation of gruel and plaque instability. Am J Pathol 149:367-380.
29. Bochaton-Piallat ML, Gabbiani F, Redard M, Desmouliere A, and Gabbiani G (1995). Apoptosis participate in cellularity regulation during rat aortic intimal thickening. Am J Pathol 146:1059-1064.
30. Bolli R (1990). Mechanism of myocardial "stunning." Circulation 82:723-738.
31. Bolli R (1992). Myocardial "stunning" in man. Circulation 86:1671-1691.
32. Bolli R, Bhatti ZA, Tang Z-L, Qiu Y, and Zhang Q (1997). Evidence that late preconditioning against myocardial stunning in conscious rabbits is triggered by the generation of nitric oxide. Circ Res 81:42-52.
33. Bolli R, Manchikalapudi S, Tang XL, Takano H, Qiu Y, Guo Y, Zhang Q, and Jadoon AK (1997). The protective effect of late preconditioning against myocardial stunning in conscious rabbits is mediated by nitric oxide synthase: Evidence that nitric oxide acts both as a trigger and as a mediator of the late phase of ischemic preconditioning. Circ Res 81:1094-1107.
34. Bolli R, Patel BS, Jeroudi MO, Lai EK, and McCay PB (1988). Demonstration of free radical generation in "stunned" myocardium of intact dogs with the use of the spin trap alpha-phenyl N-tert-butyl nitrone. J Clin Invest 82:476-485.
35. Bose S, Weikl T, Bühgl H, and Buchner J (1996). Chaperone function of Hsp90-associated proteins. Science 274:1715-1717.
36. Braunwald E (1982). Mechanism of action of calcium channel blocking agents. N Engl J Med 307:1618-1627.
37. Braunwald E and Kloner RA (1982). The stunned myocardium: Prolonged, postischemic ventricular dysfunction. Circulation 66:1146-1149.
38. Braunwald E and Kloner RA (1985). Myocardial reperfusion: A double-edge sword? J Clin Invest 76:1713-1719.
39. Braunwald E and Maroko PR (1974). The reduction of infarct size - an idea whose time (for testing) has come. Circulation 50:206-209 .
40. Buerke M, Murohara T, Skurk C, Nuss C, Tomaselli K, and Lefer AM (1995). Cardioprotective effect of insulin-like growth factor I in myocardial ischemia followed by reperfusion. Proc Natl Acad Sci USA 92:8031-8035.
41. x-containing oligosaccharide attenuates myocardial reperfusion injury in cats. J Clin Invest 93:1140-1148.
42. Buja LM (1991). Lipid abnormalities in myocardial cell injury. Trends Cardiovasc Med 1:40-45.
43. Buja LM (1995). Basic pathological processes of the heart: Relationship to cardiomyopathies. In: Sperelakis W, editor: Physiology and pathophysiology of the heart, 3rd ed. Boston: Kluwer Academic Publishers, 37-53.
44. Buja LM and Entman ML (1998). Modes of myocardial cell injury and cell death in ischemic heart disease (editorial). Circulation 98:1355-1357.
45. Buja LM and Miller JC (1997). Relationship of lipid alterations and impaired calcium homeostasis during myocardial ischemia. In: Gross RW, editor. Advances in lipobiology, Vol. 2. JAI Press, 1-28.
46. Buja LM and Willerson JT (1981a). Clinicopathologic correlates of acute ischemic heart disease syndromes. Am J Cardiol 47:343-356.
47. Buja LM and Willerson JT (1981b). Abnormalities of volume regulation and membrane integrity in myocardial tissue slices after early ischemic injury in the dog: Effects of mannitol, polyethylene glycol, and propranolol. Am J Pathol 103:79-95.
48. Buja LM and Willerson JT (1987a). Infarct size - can it be measured or modified in humans? Prog Cardiovasc Dis 29:271-289.
49. Buja LM and Willerson JT (1987b). The role of coronary artery lesions in ischemic heart disease: Insights from recent clinicopathologic, coronary arteriographic, and experimental studies. Human Pathol 18:451-461.
50. Buja LM, Eigenbrodt ML, and Eigenbrodt EH (1993). Apoptosis and necrosis: Basic types and mechanisms of cell death. Arch Pathol Lab Med 117:1208-1214.
51. Buja LM, Hagler HK, and Willerson JT (1988). Altered calcium homeostasis in the pathogenesis of myocardial ischemic and hypoxic injury. Cell Calcium 9:205-217.
52. Buja LM, Hillis LD, Petty CS, and Willerson JT (1981). The role of coronary arterial spasm in ischemic heart disease. Arch Pathol Lab Med 105:221-226.
53. Buja LM, Parkey RW, Dees JH, Stokely EM, Harris RA Jr, Bonte FJ, and Willerson JT (1975). Morphologic correlates of technetium-99 m stannous pyrophosphate imaging of acute myocardial infarcts in dogs. Circulation 52:596-607.
54. Burckhartt B, Yang X-M, Tsuchida A, Mullane KM, Downey JM, and Cohen MV (1994). Acadesine extends to the window of protection afforded by ischemic preconditioning in conscious rabbits. Cardiovasc Res 74:998-1004.
55. Burton KP, Morris AC, Massey KD, Buja LM, and Hagler HK (1990). Free radicals alter ionic calcium levels and membrane phospholipids in cultured rat ventricular myocytes. J Mol Cell Cardiol 22:1035-1047.
56. Bush LR, Buja LM, Samowitz W, Rude RE, Watham M, Tilton GD, and Willerson JT (1983). Recovery of left ventricular segmental function after long-term reperfusion following temporary coronary occlusion in conscious dogs: Comparison of 2 and 4 hour occlusions. Circ Res 53:248-263.
57. Bush LR, Buja LM, Tilton G, Wathen M, Apprill P, Ashton J, and Willerson JT (1985). Effects of propranolol and diltiazem alone and in combination on the recovery of left ventricular segmental function after temporary coronary occlusion and long-term reperfusion in conscious dogs. Circulation 72:413-430.
58. Camici PG, Wijns W, Borgers M, DeSilva R, Ferrari R, Knuuti J, Lammertsma AA, Liedtke AJ, Paternostro G, and Vatner SF (1997). Pathophysiological mechanisms of chronic reversible left ventricular dysfunction due to coronary artery disease (hibernating myocardium). Circulation 96:3205-3214.
59. Carmeliet E (1984). Myocardial ischemia: Reversible and irreversible changes. Circulation 70:149-151.
60. Casscells W, Hathorne B, David M, Krabach T, Vaughn WK, McAllister HA, Bearman G, and Willerson JT (1996). Thermal detection of cellular infiltrates in living atherosclerotic plaques: Possible implications for plaque rupture and thrombosis. Lancet 347:1447-1451.
61. Chakrabarti S, Hoque ANE, and Karmazyn M (1997). A rapid ischemia-induced apoptosis in isolated rat hearts and its attenuation by the Na-H exchange inhibitor HOE 642. J Mol Cell Cardiol 29:3169-3174.
62. Cheitlin MD, McAllister HA, and de Castro CM (1975). Myocardial infarction without atherosclerosis. JAMA 231:951-959.
63. Chen C, Ma L, Linfert DR, Lai T, Fallon JT, Gillam LD, Waters DD, and Tsongalis GJ (1997). Myocardial cell death and apoptosis in hibernating myocardium. J Am Coll Cardiol 30:1407-1412.
64. Cheng W, Kajstura J, Nitahara JA, Li B, Reiss K, Liu Y, Clark WA, Krajewski S, Reed JC, Olivetti G, and Anversa P (1996). Programmed myocyte cell death affects the viable myocardium after infarction in rats. Exp Cell Res 226:316-327.
65. Cheng W, Li B, Kajstura J, Li P, Wolin MS, Sonnenblick EH, Hintze TH, Olivetti G, and Anversa P (1995). Stretch-induced programmed myocyte cell death. J Clin Invest 96:2247-2259.
66. Cho A, Courtman DW, and Langille BL (1995). Apoptosis (programmed cell death) in arteries of the neonatal lamb. Circ Res 76:168-175.
67. Cigola E, Kajstura J, Li B, Meggs LG, and Anversa P (1997). Angiotensin II activates programmed myocyte cell death in vitro. Exp Cell Res 231:363-371.
68. + channel. J Mol Cell Cardiol 29:175-182.
69. Cohen MV and Downey JM (1995). Preconditioning during ischemia. Cardiol Rev 3:137-149.
70. Cohen MV, Yang X-M, and Downey JM (1994). Conscious rabbits become tolerant to multiple episodes of ischemic preconditioning. Circ Res 74:998-1004.
71. Collins RJ, Harmon BV, Gob 74 J GC, and Kerr JFR (1992). Internucleosomal DNA cleavage should not be the sole criterion for identifying apoptosis. Int J Radiat Biol 61:451-453.
72. Colucci WS (1996). Apoptosis in the heart. N Engl J Med 335:1224-1226.
73. Crisby M, Kallin B, Thyberg J, Zhivotovsky B, Orrenius S, Kostulas V, and Nilsson J (1997). Cell death in human atherosclerotic plaques involves both oncosis and apoptosis. Atherosclerosis 130:17-27.
74. Cumming DV, Heads RJ, Brand NJ, Yellon DM, and Latchman DS (1996). The ability of heat stress and metabolic preconditioning to protect primary rat cardiac myocytes. Basic Res Cardiol 91:79-85.
75. Currie RW, Ross BM, and Davis TA (1990). Induction of the heat shock response in rats modulates heart rate, creatine kinase and protein synthesis after a subsequent hyperthermic treatment. Cardiovasc Res 24:87-93.
76. Currie RW, Tanguay RM, and Kingma JG Jr (1993). Heat-shock response and limitation of tissue necrosis during occlusion/reperfusion in rabbit hearts. Circulation 87:963-971.
77. Das DK, Engelman RM, and Kimura Y (1993). Molecular adaptation of cellular defenses following preconditioning of the heart by repeated ischaemia. Cardiovasc Res 27:578-584.
78. Das DK, Maulik N, and Moraru II (1995). Gene expression in acute myocardial stress: Induction by hypoxia, ischemia, reperfusion, hyperthermia and oxidative stress. J Mol Cell Cardiol 27:181-193.
79. Davies MJ (1997). Apoptosis in cardiovascular disease. Heart 77:498-501.
80. de Vries JE, Vork MM, Roemen THM, de Jong YF, Cleutjens JPM, van der Vusse GJ, and van Bilsen M (1997). Saturated but not mono-unsaturated fatty acids induce apoptotic cell death in neonatal rat ventricular myocytes. J Lipid Res 38:1384-1394.
81. DeWood MA, Spores J, Notske R, Mouser LT, Burroughs R, Golden MS, and Lang HT (1980). Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. N Engl J Med 303:897-902.
82. Diamond GA, Forrester JS, de Luz PL, Wyatt HL, and Swan HJC (1978). Post-extrasystolic potentiation of ischemic myocardium by atrial stimulation. Am Heart J 95:204-209.
83. Didenko VV and Hornsby PJ (1996). Presence of double-strand breaks with single-base 3′ overhangs in cells undergoing apoptosis but not necrosis. J Cell Biol 135:1369-1376.
84. Díez J, Panizo A, Hernández M, Vega F, Sola I, Fortuño MA, and Pardo J (1997). Cardiomyocyte apoptosis and cardiac angiotensin-converting enzyme in spontaneously hypertensive rats. Hypertension 30:1029-1034.
85. Dilsizian V and Bonow RO (1993). Current diagnostic techniques of assessing myocardial viability in hibernating and stunned myocardium. Circulation 87:1-20.
86. Dimmeler S, Haendeler J, Gelle, J, and Zeiher AM (1997). Oxidized low-density lipoprotein induces apoptosis of human endothelial cells by activation of CPP32-like proteases: A mechanistic clue to the 'response to injury' hypothesis. Circulation 95:1760-1763.
87. Doeller JE and Wittenberg BA (1990). Intracellular calcium and high-energy phosphates in isolated cardiac myocytes. Am J Physiol 259:H1851-H1859.
88. Dong C, Wilson JE, Winters GL, and McManus BM (1996). Human transplant coronary artery disease: Pathological evidence for Fas-mediated apoptotic cytotoxicity in allograft arteriopathy. Lab Invest 74:921-931.
89. Downey JM (1992). Ischemic preconditioning: Nature's own cardioprotective intervention. Trends Cardiovasc Med 2:170-176.
90. Elsässer A, Schlepper M, Klövekorn W-P, Cai W-J, Zimmermann R, Mühller K-D, Strasser R, Kostin S, Gagel C, Mühnkel B, Schaper W, and Schaper J (1997). Hibernating myocardium: An incomplete adaptation to ischemia. Circulation 96:2920-2931.
91. Fadok VA, Voelker DR, Campbell PA, Cohen JJ, Bratton DL, and Henson PMJ (1992). Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol 148:2207-2216.
92. Fairbairn DW, Olive PL, and O'Neill KL (1995). The comet assay: A comprehensive review. Mutation Res 339:37-59.
93. Farb A, Kolodgie FD, Jenkins M, and Virmani R (1993). Myocardial infarct extension during reperfusion after coronary artery occlusion: Pathologic evidence. J Am Coll Cardiol 21:1245-1253.
94. Ferdinandy P, Appelbaum Y, Csonka C, Blasig IE, Das DK, and Tosaki A (1998). The role of nitric oxide and TPEN, a potent metal chelator, in ischeamic and reperfused rat hearts. Clin Exp Pharmacol Physiol 25:496-502.
95. Ferdinandy P, Szilvassy Z, Balogh N, Csonka C, Csont T, Koltai M, and Dux L (1996). Nitric oxide is involved in active preconditioning in isolated working rat hearts. Ann NY Acad Sci 793:489-493.
96. Ferdinandy P, Szilvassy Z, Csont T, Csonka C, Nagy E, Koltai M, and Dux L (1995). Nitroglycerin-induced protection of the ischemic myocardium in isolated working hearts of rats with vascular tolerance to nitroglycerin. Br J Pharmacol 115: 1129-1131.
97. Feuerstein G, Ruffolo RR Jr, and Yue T-L (1997). Apoptosis and heart failure. Trends Cardiovasc Med 7:249-255.
98. Fliss H and Gattinger D (1996). Apoptosis in ischemic and reperfused rat myocardium. Circ Res 79:949-956.
99. Freeman BC, Toft DO, and Morimoto RT (1996). Molecular chaperone machines: Chaperone activities of the cyclophilin Cyp-40 and the steroid aporeceptor-associated protein p23. Science 274:1718-1720.
100. Fuster V, Badimon L, Badimon JJ, and Chesebro JH (1992a). The pathogenesis of coronary artery disease and the acute coronary syndromes (Part 1). N Engl J Med 326:242-250.
101. Fuster V, Badimon L, Badimon JJ, and Chesebro JH (1992b). The pathogenesis of coronary artery disease and the acute coronary syndromes (Part 2). N Engl J Med 326:310-318.
102. Ganote CE and Vander Heide RS (1987). Cytoskeletal lesions in anoxic myocardial injury: A conventional and high voltage electron-microscopic and immunofluorescence study. Am J Pathol 129:327-334.
103. Ganz W, Buchbinder N, Marcus H, Mondkar A, Maddahi J, Charuzi Y, O'Connor L, Shell W, Fishbein MC, Kass R, Miyamoto A, and Swan HJ (1981). Intracoronary thrombolysis in evolving myocardial infarction. Am Heart J 101:4-13.
104. 2+ responsiveness and altered diastolic function in intact ventricular muscle. Circ Res 76:1036-1048.
105. 2+-dependent proteolysis? Circ Res 78:455-465.
106. + channels: Possible mechanism of cardioprotection. Circ Res 81:1072-1082.
107. Gavrieli Y, Sherman Y, and Ben-Sasson SA (1992). Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119:493-501.
108. Geng Y-J and Libby P (1995). Evidence for apoptosis in advanced human atheroma Colocalization with interleukin-1β-converting enzyme. Am J Pathol 147:251-266.
109. Geng YJ, Wu Q, Muszynski M, Hansson GK, and Libby P (1996). Apoptosis of vascular smooth muscle cells induced by in vitro stimulation with interferon-gamma, tumor necrosis factor-alpha, and interleukin-1 beta. Arterioscler Thromb Vasc Biol 16:19-27.
110. Gerschenson LE and Rotello RJ (1992). Apoptosis: A different type of cell death. FASEB J 6:2450-2455.
111. Gilmore AP and Burridge K (1996a). Regulation of vinculin binding to talin and actin by phosphatidyl-inonsitol-4-5-bisphosphate. Nature 381:531-535.
112. Gilmore AP and Burridge K (1996b). Molecular mechanisms for focal adhesion assembly through regulation of protein-protein interactions. Structure 4:647-651.
113. Gold R, Schmied M, Giegerich G, Breitschopf H, Hartung HP, Tokya KV, and Lassman H (1994). Differentiation between cellular apoptosis and necrosis by the combined use of in situ tailing and nick translation. Lab Invest 71:219-225.
114. Gong L, Kamitani T, Fujise K, Caskey LS, and Yeh ETH (1997). Preferential interaction of sentrin with a ubiquitin-conjugating enzyme, Ubc9. J Biol Chem 272:28198-28201.
115. Gorza L, Menabó R, Di Lisa F, and Vitadello M (1997). Troponin T cross-linking in human apoptotic cardiomyocytes. Am J Pathol 150:2087-2097.
116. Goto M, Liu Y, Yang X-M, Ardell JL, Cohen MV, and Downey JM (1995). Role of bradykinin in protection of ischemic preconditioning in rabbit hearts. Circ Res 77:611-621.
117. Gottlieb RA, Burleson KO, Kloner RA, Babior BM, and Engler RL (1994). Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J Clin Invest 94:1621-1628.
118. Gottlieb RA, Groul DL, Zhu JY, and Engler RL (1996). Preconditioning in rabbit cardiomyocytes: Role of pH, vacuolar proton ATPase, and apoptosis. J Clin Invest 97:2391-2398.
119. Granville DJ, Carthy CM, Hunt DWC, and McManus BM (1998). Apoptosis: Molecular aspects of cell death and disease. Lab Invest 78:893-913.
120. Green DW, Murray HN, Sleph PG, Wang FL, Baird AJ, Rogers WL, and Grover GJ (1998). Preconditioning in rat hearts is independent of mitochondrial F1F0 ATPase inhibition. Am J Physiol 274(1 Pt 2):H90-H97.
121. Gross GJ, Mei DA, Sleph PG, and Grover GJ (1997). Adenosine A1 receptor blockade does not abolish the cardioprotective effects of the adenosine triphosphate-sensitive potassium channel opener bimakalim. J Pharmacol Exp Ther 280:533-540.
122. Gruentzig AR, Senning A, and Siegenthaler WE (1979). Non-operative dilatation of coronary artery stenosis: Percutaneous transluminal coronary angioplasty (PTCA). N Engl J Med 301:61-68.
123. Gunnar RM, Passamani ER, Bourdillon PD, Pitt B, Dixon DW, Rapaport E, Fuster V, Reeves TJ, Karp RB, Russell RO Jr, Kennedy JW, Sobel BE, Klocke FJ, and Winters WL Jr (1990). Guidelines for the early management of patients with acute myocardial infarction. J Am Coll Cardiol 16:249-292.
124. Hagler HK and Buja LM (1990). Subcellular calcium shifts in ischemia and reperfusion. In: Piper HM, editor. Pathophysiology of severe ischemic myocardial injury. Dordrecht/ Boston/London: Academic Publishers, 283-296.
125. Hamet P, Richard L, Dam T-V, Teiger E, Orlov SN, Gaboury L, Gossard F, and Tremblay J (1995). Apoptosis in target organs of hypertension. Hypertension 26:642-648.
126. Han DKM, Haudenschild CC, Hong MK, Tinkle BT, Leon MB, and Liau G (1995). Evidence for apoptosis in human atherogenesis and in a rat vascular injury model. Am J Pathol 147:267-277.
127. Hasebe N, Shen YT, and Vatner SF (1993). Inhibition of endothelium-derived relaxing factor enhances myocardial stunning in conscious dogs. Circulation 88:2862-2871.
128. Haunstetter A and Izumo S (1998). Apoptosis: Basic mechanisms and implications for cardiovascular disease. Circ Res 82:1111-1129.
129. Hawkins HK, Entman ML, Zhu JY, Youker KA, Berens K, Doré M, and Smith CW (1996). Acute inflammatory reaction after myocardial ischemic injury and reperfusion: Development and use of a neutrophil-specific antibody. Am J Pathol 148:1957-1969.
130. Heads RJ, Latchman DS, and Yellon DM (1994). Stable high level expression of a transfected human HSP70 gene protects a heart-derived muscle cell line against thermal stress. J Mol Cell Cardiol 26:695-699.
131. Heads RJ, Latchman DS, and Yellon DM (1995). Differential stress protein mRNA expression during early ischaemic preconditioning in the rabbit heart and its relationship to adenosine receptor function. J Mol Cell Cardiol 27:2133-2148.
132. Hearse DJ and Bolli R (1991). Reperfusion-induced injury: Manifestations, mechanisms and clinical relevance. Trends Cardiovasc Med 1:233-240.
133. Hetts SW (1998). To die or not to die: An overview of apoptosis and its role in disease. JAMA 279:300-307.
134. Heusch G, Rose J, Skyschally ARJ, Post H, and Schulz R (1996). Calcium responsiveness in regional myocardial short-term hibernation and stunning in the in situ porcine heart: Inotropic responses to postextrasystolic potentiation and intracoronary calcium. Circulation 93:1556-1566.
135. Heyndrickx GR, Millard RW, McRitchie RJ, Maroko PR, and Vatner SF (1975). Regional myocardial functional and electrophysiological alterations after brief coronary artery occlusion in conscious dogs. J Clin Invest 56:978-985.
136. Higuchi M, Aggarwal BB, and Yeh ETH (1997). Activation of CPP 32-like protease in tumor necrosis factor-induced apoptosis is dependent on mitochondrial function. J Clin Invest 99:1751-1758.
137. Hillis LD and Braunwald E (1977a). Myocardial ischemia. Pt 1. N Engl J Med 296:971-978.
138. Hillis LD and Braunwald E (1977b). Myocardial ischemia. Pt 2. N Engl J Med 296:1034-1041.
139. Hillis LD and Braunwald E (1977c). Myocardial ischemia. Pt 3. N Engl J Med 296:1093-1096.
140. Hoag JB, Qian YZ, Nayeem MA, D'Angelo M, and Kukreja RC (1997). ATP-sensitive potassium channel mediates delayed ischemic protection by heat stress in rabbit heart. Am J Physiol 273(5 Pt 1):H2458-H2464.
141. Hochstrasser M (1996). Ubiquitin-dependent protein degradation. Annu Rev Genet 30:405-439.
142. Hockenbery D (1995). Defining apoptosis. Am J Pathol 146: 16-19.
143. Honan MB, Harrell FE Jr, Reimer KA, Califf RM, Mark DB, Pryor DB, and Hlatky MA (1990). Cardiac rupture, mortality and the timing of thrombolytic therapy: A meta-analysis. J Am Coll Cardiol 16:359-367.
144. Hutter MM, Sievers RE, Barbosa V, and Wolfe CL (1994). Heat-shock protein induction in rat hearts: A direct correlation between the amount of heat-shock protein induced and the degree of myocardial protection. Circulation 89:355-360.
145. Isner JM, Kearney M, Bortman S, and Passeri J (1995). Apoptosis in human atherosclerosis and restenosis. Circulation 91:2703-2711.
146. Ito H, Tomooka T, Sakai N, Higashino Y, Fujii K, Katoh O, Masuyama T, Kitabatake A, and Minamino T (1993). Time course of functional improvement in stunned myocardium in risk area in patients with reperfused anterior infarction. Circulation 87:355-362.
147. Itoh G, Jie T, Tamura J, Suzuki M, Suzuki Y, Ikeda H, and Nomura M (1996). Apoptosis and human ischemic myocardial damage, including conduction system. Basic Appl Myol 6:237-240.
148. Itoh G, Tamura J, Suzuki M, Suzuki Y, Ikeda H, Koibe M, Nomura, M, Jie T, and Iko K (1995). DNA fragmentation of human infarcted myocardial cells demonstrated by the nick end labeling method and DNA agarose gel electrophoresis. Am J Pathol 146:1235-1331.
149. Jagasia D, Whiting JM, and McNulty PH (1996). Ischemic preconditioning fails to produce a second window of protection 24 hrs later in the rat (abstract). Circulation 94:1184-1185.
150. James TN (1994). Normal and abnormal consequences of apoptosis in the human heart from postnatal morphogenesis to paroxysmal arrhythmias. Circulation 90:556-573.
151. James TN, Nichols MM, Sapire DW, DiPatre PL, and Lopez SM (1996a). Complete heart block and fatal right ventricular failure in an infant. Circulation 93:1588-1600.
152. James TN, St. Martin E, Willis PW III, and Lohr TO (1996b). Apoptosis as a possible cause of gradual development of complete heart block and fatal arrhythmias associated with absence of the AV node, sinus node and internodal pathways. Circulation 93:1424-1438.
153. Jansen DE, Corbett JR, Buja LM, Hansen C, Ugolini V, Parkey RW, and Willerson JT (1987). Quantification of myocardial injury produced by temporary coronary artery occlusion and reflow with technetium-99 m pyrophosphate. Circulation 75:611-617.
154. Jones RL, Miller JC, Hagler HK, Chien KR, Willerson JT, and Buja LM (1989). Association between inhibition of arachidonic acid release and prevention of calcium loading during ATP depletion in cultured neonatal rat cardiac myocytes. Am J Pathol 135:541-556.
155. Kajstura J, Cheng W, Reiss K, Clark WA, Sonnenblick EH, Krajewski S, Reed JC, Olivetti G, and Anversa P (1996a). Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats. Lab Invest 74:86-107.
156. Kajstura J, Cheng W, Sarangarajan R, Li P, Li B, Nitahara JA, Chapnick S, Reiss K, Olivetti G, and Anversa P (1996b). Necrotic and apoptotic myocyte cell death in the aging heart of Fischer 344 rats. Am J Physiol 271(3 Pt 2):H1215-H1228.
157. Kajstura J, Cigola E, Malhotra A, Li P, Cheng W, Meggs LG, and Anversa P (1997). Angiotensin II induces apoptosis of adult ventricular myocytes in vitro. J Mol Cell Cardiol 29:859-870.
158. Kajstura J, Mansukhani M, Cheng W, Reiss K, Krajewski S, Reed JC, Quaini F, Sonnenblick EH, and Anversa P (1995). Programmed cell death and expression of the protooncogene bcl-1 in myocytes during postnatal maturation of the heart. Exp Cell Res 219:110-121.
159. Kajstura J, Zhang X, Reiss K, Szoke E, Li P, Lagrasta C, Cheng W, Darzynkiewicz Z, Olivetti G, and Anversa P (1994). Myocyte cellular hyperplasia and myocyte cellular hypertrophy contribute to chronic ventricular remodeling in coronary artery narrowing-induced cardiomyopathy in rats. Circ Res 74:383-400.
160. Kamitani T, Nguyen HP, and Yeh ETH (1997). Activation-induced aggregation and processing of the human Fas antigen. J Biol Chem 272:22307-22314.
161. Kamitani T, Nguyen HP, Kito K, Fukuda-Kamitani T, and Yeh ETH (1998). Covalent modification of PML by the sentrin family of ubiquitin-like proteins. J Biol Chem 273:3117-3120.
162. 2+, and apoptosis in neonatal cardiomyocytes during metabolic inhibition/recovery. Circ Res 82:1139-1144.
163. Kelly RA, Balligand J-L, and Smith TW (1996). Nitric oxide and cardiac function. Circ Res 79:363-380.
164. Kerr JFR, Wylie AH, and Currie AR (1972). Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26:239-257.
165. Kim S-J, Ghaleh B, Kudej RK, Huang CH, Hintze TH, and Vatner SF (1997). Delayed enhanced nitric oxide-mediated coronary vasodilatation following brief ischemia and prolonged reperfusion in conscious dogs. Circ Res 81:53-59.
166. Kirshenbaum LA and de Moissac D (1997). The bcl-2 gene product prevents programmed cell death of ventricular myocytes. Circulation 96:1580-1585.
167. Kloner RA, Bolli R, Marban E, Reinlib L, and Braunwald E (1998). Medical and cellular implications of stunning, hibernation, and preconditioning: An NHLBI workshop. Circulation 97:1848-1867.
168. Kloner RA, Przyklenk K, and Patel B (1989a). Altered myocardial states: The stunned and hibernating myocardium. Am J Med 86(suppl 1A):14-21.
169. Kloner RA, Przyklenk K, and Whittaker D (1989b). Deleterious effects of oxygen radicals in ischemia/reperfusion: Resolved and unresolved issues. Circulation 80:1115-1127.
170. Kluck RM, Bossy-Wetzel E, Green DR, and Newmeyer DD (1997). The release of cytochrome c from mitochondria: A primary site for bcl-2 regulation of apoptosis. Science 275: 1132-1136.
171. Knowlton AA, Brecher P, and Apstein CS (1991). Rapid expression of heat shock protein in the rabbit after brief cardiac ischemia. J Clin Invest 87:139-147.
172. Kolocassides K, Galinanes M, and Hearse DJ (1996). Dichotomy of ischemic preconditioning: Improved postischemic contractile function despite intensification of ischemic contracture. Circulation 93:1725-1733.
173. Kontos MC, Shipley JB, and Kukreja RC (1996). Heat stress improves functional recovery and induces synthesis of 27-and 70-kDa heat shock proteins without preserving sarcoplasmic reticulum function in the ischemic rat heart. J Mol Cell Cardiol 28:1885-1894.
174. l, elevation and ATP depletion. Am J Physiol 258:H9-H16.
175. Koretsune Y, Corretti MC, Kusuoka H, and Marban E (1991). Mechanism of early ischemic contractile failure: Inexcitability, metabolite accumulation or vascular collapse? Circ Res 68:255-262.
176. Krown KA, Page MT, Nguyen C, Zechner D, Gutierrez V, Comstock KL, Glembotski C, Quintana PJE, and Sabbadini RA (1996). Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes: Involvement of the sphingolipid signalling cascade in cardiac cell death. J Clin Invest 98:2854-2865.
177. Kukreja RC, Kontos MC, and Hess ML (1996). Free radicals and heat shock protein in the heart. Ann NY Acad Sei 793:108-122.
178. Kusuoka H and Marban E (1992). Cellular mechanisms of myocardial stunning. Annu Rev Physiol 54:243-256.
179. 2+ activation of contraction as a consequence of reperfusion-induced cellular calcium overload in ferret hearts. J Clin Invest 79:950-961.
180. Kuzuya T, Hoshida S, Yamashita N, Fuji H, Oe H, Hori M, Kamada T, and Tada M (1993). Delayed effects of sublethal ischemia on the acquisition of tolerance to ischemia. Circ Res 72:1293-1299.
181. Landry J and Huot J (1995). Modulation of actin dynamics during stress and physiological stimulation by a signalling pathway involving p38 MAP kinase and heat shock protein 27. Biochem Cell Biol 73:703-707.
182. Lavie CJ and Gersh BJ (1990). Mechanical and electrical complications of acute myocardial infarction. Mayo Clinic Proc 65:709-730.
183. Lee HC, Monhabir R, Smith N, Franz MR, and Clusin WT (1988). Effect of ischemia on calcium-dependent fluorescence transients in rabbit hearts containing indo-1. Circulation 78:1047-1059.
184. Lefer DJ, Nakanishi K, Johnston WE, and Vinten-Johansen J (1993). Antineutrophil and myocardial protecting actions of a novel nitric oxide donor after acute myocardial ischemia and reperfusion in dogs. Circulation 88:2337-2350.
185. Leri A, Claudio PP, Li Q, Wang X, Reiss K, Wang S, Malhotra A, Kajstura J, and Anversa P (1998a). Stretch-mediated release of angiotensin II induces myocyte apoptosis by activating p53 that enhances the local renin-angiotensin system and decreases the Bcl-2 to Bax protein ratio in the cell. J Clin Invest 101:1326-1342.
186. Leri A, Liu Y, Malhotra A, Li Q, Stiegler P, Claudio PP, Giordano A, Kajstura J, Hintze TH, and Anversa P (1998b). Pacing-induced heart failure in dogs enhances the expression of p53 and p53-dependent genes in ventricular myocytes. Circulation 97:194-203.
187. Leszczynski D, Zhao Y, Luokkamäki M, and Foegh ML (1994). Apoptosis of vascular smooth muscle cells: Protein kinase C and oncoprotein Bcl-2 are involved in regulation of apoptosis in non-transformed rat vascular smooth muscle cells. Am J Pathol 145:1265-1270.
188. Lewandowski ED, Yu X, LaNoue KF, White LT, Dowmen C, and O'Donnell JM (1997). Altered metabolite exchange between subcellular compartments in intact postischemic hearts. Circ Res 81:165-175.
189. Li Q, Li B, Wang X, Leri A, Jana KP, Liu Y, Kajstura J, Baserga R, and Anversa P (1997a). Overexpression of insulin-like growth factor-1 in mice protects from myocyte death after infarction, attenuating ventricular dilatation, wall stress and cardiac hypertrophy. J Clin Invest 100:1991-1999.
190. Li Z, Bing OHL, Long X, Robinson KG, and Lakatta EG (1997b). Increased cardiomyocyte apoptosis during the transition of heart failure in the spontaneously hypertensive rat. Am J Physiol 272:H2313-H2319.
191. 1 adenosine receptors in rabbit heart. Circulation 84:350-356.
192. Liu X, Kim CN, Yang J, Jemmerson R, and Wang X (1996). Induction of apoptotic program in cell-free extracts: Requirement for dATP and cytochrome c. Cell 86:147-157.
193. Liu Y and Kitsis RN (1996). Induction of DNA synthesis and apoptosis in cardiac myocytes by EIA oncoprotein. J Cell Biol 122:325-334.
194. Liu Y, Cigola E, Cheng W, Kajstura J, Olivetti G, Hintze TH, and Anversa P (1995). Myocyte nuclear mitotic division and programmed myocyte cell death characterize the cardiac myopathy induced by rapid ventricular pacing in dogs. Lab Invest 73:771-787.
195. + currents by protein kinase C and adenosine: Implications for ischemic preconditioning. Circ Res 78:443-454.
196. Long X, Boluyt MO, Hipolito M de L, Lundberg MS, Zheng J-S, O'Neill L, Cirielli C, Lakatta EG, and Crow MT (1997). p53 and the hypoxia-induced apoptosis of cultured neonatal rat cardiac myocytes. J Clin Invest 99:2635-2643.
197. Long X, Crow MT, Sollott SJ, O'Neill L, Menees DS, de Lourdes Hipolito M, Boluyt MO, Asai T, and Lakatta EG (1998). Enhanced expression of p53 and apoptosis induced by blockade of the vacuolar proton ATPase in cardiomyocytes. J Clin Invest 101:1453-1461.
198. Lu H-R, Remeysen P, and De Clerk F (1995). Does the antiarrhythmic effect of ischemic preconditioning in rats involve the L-arginine nitric oxide pathway? J Cardiovasc Pharmacol 25:524-530.
199. MacLellan WR and Schneider MD (1997). Death by design: Programmed cell death in cardiovascular biology and disease. Circ Res 81:137-144.
200. Majno G and Joris I (1995). Apoptosis, oncosis, and necrosis: An overview of cell death. Am J Pathol 146:3-15.
201. Maldonado C, Qiu Y, Tang X-L, Cohen MV, Auchampach J, and Bolli R (1997). Role of adenosine receptors in late preconditioning against myocardial stunning in conscious rabbits. Am J Physiol 273(3 Pt 2):H1324-H1332.
202. Mallat Z, Ohan J, Lesèche G, and Tedgui A (1997). Colocalization of CPP-32 with apoptotic cells in human atherosclerotic plaques. Circulation 96:424-428.
203. Mallat Z, Tedgui A, Fontaliran F, Frank R, Durigon M, and Fontaine G (1996). Evidence of apoptosis in arrhythmogenic right ventricular dysplasia. N Engl J Med 335:1190-1196.
204. Marban E (1991). Myocardial stunning and hibernation: The physiology behind the colloquialisms. Circulation 83:681-688.
205. Marber MS, Latchman DS, Walker JM, and Yellon DM (1993). Cardiac stress protein elevation 24 hours after brief ischemia or heat stress is associated with resistance to myocardial infarction. Circulation 88:1264-1272.
206. Marber MS, Mestril R, Chi SH, Sayen MR, Yellon DM, and Dillmann WH (1995). Overexpression of the rat inducible 70-kD heat stress protein in a transgenic mouse increases the resistance of the heart to ischemic injury. J Clin Invest 94:1446-1456.
207. 2+. Oncogene 12:2259-2266.
208. Maulik N, Kagan VE, Tyurin V, and Das DK (1998). Redistribution of phosphatidylethanolamine and phosphatidylserine precedes the reperfusion-induced apoptosis in heart. Am J Physiol 274(1 Pt 2):H242-H248.
209. Maulik N, Watanabe M, Zu YL, Huang CK, Cordis GA, Schley JA, and Das DK (1996). Ischemic preconditioning triggers the activation of MAP kinases and MAPKAP kinase 2 in rat hearts. FEBS Lett 396:233-237.
210. McDonald TJ (1993). Cell division versus cell death: A functional model of multistep neoplasia. Mol Carcinogen 8:209-213.
211. Mei DA, Elliott GT, and Gross GJ (1996). KATP channels mediate late preconditioning against infarction produced by monophosphoryl lipid A. Am J Physiol 271(6 Pt 2):H2723-H2729.
212. Melillo G, Lima JAC, Judd RM, Goldschmidt-Clermont PJ, and Silverman HS (1996). Intrinsic myocyte dysfunction and tyrosine kinase pathway activation underlie the impaired wall thickening of adjacent regions during postinfarct left ventricular remodeling. Circulation 93:1447-1458.
213. Milunski MR, Mohr GA, Perez JE, Vered Z, Wear KA, Gessler CJ, Sobel BE, Miller JG, and Wickline SA (1989). Ultrasonic tissue characterization with integrated backscatter: Acute myocardial ischemia, reperfusion, and stunned myocardium in patients. Circulation 80:491-503.
214. Misao J, Hayakawa Y, Ohno MJ, Kato S, Ujiwara T, and Fujiwara H (1996). Expression of bcl-2 protein, an inhibitor of apoptosis, and Bax, an accelerator of apoptosis in ventricular myocytes of human hearts. Circulation 94:1506-1512.
215. Morita K, Sherman MP, Buckberg GD, Ihnken K, Matheis G, Young HH, and Ignarro LJ (1995). Studies of hypoxemic/reoxygenation injury: Without aortic clamping - V. Role of the L-arginine-NO pathway: The nitric oxide paradox. J Thorac Cardiovasc Surg 110:1200-1211.
216. + pump inhibition in cultured neonatal rat cardiac myocytes. J Clin Invest 83:1876-1877.
217. Muntz KH, Hagler HK, Boulas JH, Willerson JT, and Buja LM (1984). Redistribution of catecholamines in the ischemic zone of dog heart. Am J Pathol 114:64-78.
218. Murry CE, Jennings RB, and Reimer KA (1986). Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium. Circulation 74:1124-1136.
219. Murry CE, Richard VJ, Jennings RB, and Reimer KA (1991). Myocardial protection is lost before contractile function recovers from ischemic preconditioning. Am J Physiol 260: H796-H804.
220. Murry CE, Richard VJ, Reimer KA, and Jennings RB (1990). Ischemic preconditioning slows energy metabolism and delays ultrastructural damage during a sustained ischemic episode. Circ Res 66:913-931.
221. Nagata S and Golstein P (1995). The fas death factor. Science 267:1449-1455.
222. Narula J, Haider N, Virmani R, DiSalvo TG, Kolodgie FD, Hajjar RJ, Schmidt U, Semigran MJ, Dec GW, and Khaw B-A (1996). Apoptosis in myocytes in end-stage heart failure. N Engl J Med 335:1182-1189.
223. Nayeem MA, Hess ML, Qian YZ, Loesser KE, and Kukreja RC (1997). Delayed preconditioning of cultured adult rat cardiac myocytes: Role of 70- and 90-kDa heat shock proteins. Am J Physiol 273(2 Pt 2):H861-H868.
224. Nguyen ND and Buja LM (1994). The role of ventricular wall stress in cardiac hypertrophy. Cardiovasc Pathol 3:19-31.
225. Nitahara JA, Cheng W, Liu Y, Li B, Leri A, Li P, Mogul D, Gambert SR, Kajstura J, and Anversa P (1998). Intracellular calcium, Dnase activity and myocyte apoptosis in aging Fischer 344 rats. J Mol Cell Cardiol 30:519-535.
226. Nolan AC, Clark WA, Karwoski T, and Zak R (1983). Patterns of cellular injury in myocardial ischemia determined by monoclonal antimyosin. Proc Natl Acad Sci USA 80:6046-6050.
227. Ohno M, Takemura G, Ohno A, Misao J, Hayakawa Y, Minatoguchi S, Fujiwara T, and Fujiwara H (1998). "Apoptotic myocytes" in the infarct area in rabbit hearts may be oncotic myocytes with DNA fragmentation: Analysis by immunogold electron microscopy combined with in situ nick end labeling. Circulation 98:1422-1430.
228. Okura T, Gong L, Kamitani T, Wada T, Okura I, Wei C-F, Chang H-M, and Yeh ETH (1996). Protection against Fas/APO-1- and tumor necrosis factor-mediated cell death by a novel protein, sentrin. J Immunol 157:4277-4281.
229. Olivetti G, Abbi R, Quaini F, Kajstura J, Cheng W, Nitahara JA, Quaini E, Di Loreto C, Beltrami CA, Krajewski S, Reed JC, and Anversa P (1997). Apoptosis in the failing human heart. N Engl J Med 336:1131-1141.
230. nd Ed. New York: Churchill Livingstone, 671-717.
231. Page DL, Caulfield JB, Kastor JA, De Sanctis RW, and Sanders CA (1971). Myocardial changes associated with cardiogenic shock. N Engl J Med 285:133-137.
232. Pahl HL and Baeuerle PA (1994). Oxygen and the control of gene expression. Bioessays 16:497-502.
233. Patel T, Gores GJ, and Kaufmann SH (1996). The role of proteases during apoptosis. FASEB J 10:587-597.
234. Perlman H, Maillard L, Krasinski K, and Walsh K (1997). Evidence for the rapid onset of apoptosis in medial smooth muscle cells after balloon injury. Circulation 95:981-987.
235. Perry DK, Obeid LM, and Hannun YA (1996). Ceramide and the regulation of apoptosis and the stress response. Trends Cardiovasc Med 6:158-162.
236. Pfeffer MA and Braunwald E (1990). Ventricular remodeling after myocardial infarction: Experimental observations and clinical implications. Circulation 81:1161-1172.
237. Ping P, Zhang J, Qiu Y, Tang X-L, Manchikalapudi S, Gao X, and Bolli R (1997). Ischemic preconditioning induces selective translocation of protein kinase C isoforms epsilon and eta in the heart of conscious rabbits without subcellular redistribution of total protein kinase C activity. Circ Res 81:404-414.
238. Pinsky DJ, Yang Y, Aji W, Szaboles M, Liao H, Sciacca RR, and Cannon PJ (1995). Nitric oxide induced apoptosis of adult rat cardiac myocytes. Circulation (Suppl 1) 92:565-566.
239. Plot CA, Padmanaban D, Ursell PC, Sievers RE, and Wolfe CL (1997). Ischemic preconditioning decreases apoptosis in rat hearts in vivo. Circulation 96:1598-1604.
240. Plumier JC, Ross BM, Currie RW, Angelidis CE, Kazlaris H, Kollias G, and Pagoulatos GN (1995). Transgenic mice expressing the human heat shock protein 70 have improved post-ischemic myocardial recovery. J Clin Invest 94:1854-1860.
241. Qian Y-Z, Shipley JB, Levasseur JE, and Kukreja RC (1998). Dissociation of heat shock protein expression with ischemic tolerance by whole body hyperthermia in rat heart. J Mol Cell Cardiol 30:1163-1172.
242. ATP channels in rat heart: Blockade of ischemic and acetylcholine-mediated preconditioning by glibenclamide. Am J Physiol 271:H23-H18.
243. Qiu Y, Rizvi A, Tang XL, Manchikalapudi S, Takano H, Jadoon AK, Wu WJ, and Bolli R (1997b). Nitric oxide triggers late preconditioning against myocardial infarction in conscious rabbits. Am J Physiol 273(6 Pt 2):H2931-H2936.
244. Qiu Y, Tang XL, Park SW, Sun JZ, Kalya A, and Bolli R (1997a). The early and late phases of ischemic preconditioning: A comparative analysis of their effects on infarct size, myocardial stunning, and arrhythmias in conscious pigs undergoing a 40-minute coronary occlusion. Circ Res 80:730-742.
245. Quillet-Mary A, Jaffrézou J-P, Mansat V, Bordier C, Naval J, and Laurent G (1997). Implication of mitochondrial hydrogen peroxide generation in ceramide-induced apoptosis. J Biol Chem 272:21388-21395.
246. 201Tl uptake and comparative prediction of recovery of function. Circulation 95:626-635.
247. Rahimtoola SH (1989). The hibernating myocardium. Am Heart J 117:211-221.
248. Reimer KA (1996). The slowing of ischemic energy demand in preconditioned myocardium. Ann NY Acad Sci 793:13-26.
249. Reimer KA and Ideker RE (1987). Myocardial ischemia and infarction: Anatomic and biochemical substrates for ischemic cell death and ventricular arrhythmias. Human Pathol 18: 462-475.
250. Reimer KA and Jennings RB (1979). The "wavefront phenomenon" of myocardial ischemic cell death: Part II. Transmural progression of necrosis within the framework of ischemic bed size (myocardium at risk) and collateral flow. Lab Invest 40:633-644.
251. Reimer KA and Jennings RB (1991). Myocardial ischemia, hypoxia, and infarction. In: Fozzard HA, Haber E, Jennings RB, Katz AM, and Morgan HE, editors. The Heart and Cardiovascular System: Scientific Foundations, 2ndedition. New York: Raven Press, 1875-1973.
252. Reimer KA and Jennings RB (1996). Ischemic preconditioning: A brief review. Basic Res Cardiol 91:1-4.
253. Reimer KA, Jennings RB, Cobb FR, Murdock RH, Greenfield JC Jr, Becker LC, Healey Bulkley B, Hutchins GM, Schwartz RP Jr, Bailey KR, and Passamani ER (1985). Animal models for protecting ischemic myocardium (AMPIM): Results of the NHLBI Cooperative Study: Comparison of unconscious and conscious dog models. Circ Res 56:651-665.
254. Rentrop KP (1995). Restoration of antegrade flow in acute myocardial infarction: The first 15 years. J Am Coll Cardiol 25(Suppl 7):1S-2S.
255. Rink A, Fung K-M, Trojanowski JQ, Lee VM-Y, Neugebauer E, and McIntosh TK (1995). Evidence of apoptotic cell death after experimental traumatic brain injury in the rat. Am J Pathol 147:1575-1583.
256. Ryan TJ, Anderson JL, Antman EM, Braniff BA, Brooks NH, Califf RM, Hillis LD, Hiratzka LF, Rapaport E, Riegel BJ, Russell RO, Smith III EE, and Weaver WD (1996). ACC/AHA guidelines for the management of patients with acute myocardial infarction. J Am Coll Cardiol 28:1328-1428.
257. Saraste A, Pulkki K, Kallajoki M, Henriksen K, Parvinen M, and Voipio-Pulkki L-M (1997). Apoptosis in human acute myocardial infarction. Circulation 95:320-323.
258. Sato H, Zhao ZQ, McGee DS, Williams MW, Hammon JW, and Vinten-Johansen J (1995). Supplemental L-arginine during cardioplegic arrest and reperfusion avoids regional postischemic injury. J Thorac Cardiovasc Surg 110:302-314.
259. Sato S, Sato N, Kudej RK, Uechi M, Asai K, Shen YT, Ishikawa Y, Vatner SF, and Vatner DE (1997). Beta-adrenergic receptor signalling in stunned myocardium of conscious pigs. J Mol Cell Cardiol 29:1387-1400.
260. Schaefer S, Schwartz GG, Gober JR, Wong AK, Camacho SA, Massie B, and Weiner MW (1990). Relationship between myocardial metabolites and contractile abnormalities during graded regional ischemia: Phosphorous-31 nuclear magnetic resonance studies of porcine myocardium in vivo. J Clin Invest 85:706-713.
261. Schlesinger MJ and Reiner L (1955). Focal myocytolysis of the heart. Am J Pathol 31:443-459.
262. Schlüter KD, Jakob G, Ruiz-Meana M, Garcia-Dorado D, and Piper HM (1996). Protection of reoxygenated cardiomyocytes against osmotic fragility by nitric oxide donors. Am J Physiol 271:H428-H434.
263. ATP channel antagonist, 5-hydroxydecanoate, blocks ischemic preconditioning in the rat heart. J Mol Cell Cardiol 29:1055-1060.
264. Schultz JE, Yao Z, Cavero I, and Gross GJ (1997a). Glibenclamide-induced blockade of ischemic preconditioning is time dependent in intact rat heart. Am J Physiol 272(6 Pt 2):H2607-2615.
265. Schultz JJ, Hsu AK, and Gross GJ (1997c). Ischemic preconditioning is mediated by a peripheral opioid receptor mechanism in the intact rat heart. J Mol Cell Cardiol 29:1355-1362.
266. Schultz JJ, Hsu AK, and Gross GJ (1997d). Ischemic preconditioning and morphine-induced cardioprotection involve the delta (delta)-opioid receptor in the intact rat heart. J Mol Cell Cardiol 29:2187-2195.
267. Schwartz ER, Schaper J, von Dahl J, Altehoefer C, Grohmann B, Schoendube F, Sheehan FH, Uebis R, Buell U, Messmer BJ, Schaper W, and Hamrath P (1996). Myocyte degeneration and cell death in hibernating human myocardium. J Am Coll Cardiol 27:1577-1585.
268. Schwartz SM and Bennett MR (1995). Death by any other name. Am J Pathol 147:229-234.
269. Searle J, Kerr JFR, and Bishop CJ (1982). Necrosis and apoptosis: Distinct modes of cell death with fundamentally different significance. Pathol Annu 17(pt 2):229-259.
270. Sebbag L, Katsuragawa M, Verbinski S, Jennings RB, and Reimer KA (1996). Intracoronary administration of the alpha 1-receptor agonist, methoxamine, does not reproduce the infarct-limiting effect of ischemic preconditioning in dogs. Cardiovasc Res 32:830-838.
271. Seino K, Kayagaki W, Bashuda H, Okumura K, and Yagita H (1996). Contribution of Fas ligand to cardiac allograft rejection. Int Immunol 8:1347-1354.
272. Sharma AD, Saffitz JE, Lee BI, Sobel RE, and Corr PB (1983). Alpha adrenergic-mediated accumulation of calcium in reperfused myocardiium. J Clin Invest 72:802-818.
273. Sharov VG, Sabbah HN, Shimoyama H, Goussev AV, Lesch M, and Goldstein S (1996). Evidence of cardiomyocyte apoptosis in myocardium of dogs with chronic heart failure. Am J Pathol 148:141-149.
274. Simpson PJ and Lucchesi BR (1987). Free radicals and myocardial ischemia and reperfusion injury. J Lab Clin Med 110:13-30.
275. Smart SC, Sawada S, Ryan T, Segar D, Atherton L, Berkovitz K, Bourdillon PDV, and Feigenbaum H (1993). Low-dose dobutamine echocardiography detects reversible dysfunction after thrombolytic therapy of acute myocardial infarction. Circ Res 88:405-415.
276. Sollner-Webb B, Melchior W Jr, and Fekenfeld G (1978). DNAse I, DNAse II and staphylococcal nuclease cut at different, yet symmetrically located, sites in the nucleosome core. Cell 14:611-627.
277. Steenbergen C, Hill ML, and Jennings RB (1985). Volume regulation and plasma membrane injury in aerobic, anaerobic, and ischemic myocardium in vitro: Effects of osmotic cell swelling on plasma membrane integrity. Circ Res 57:864-875.
278. Steenbergen C, Hill ML, and Jennings RB (1987). Cytoskeletal damage during myocardial ischemia: Changes in vinculin immunofluorescence staining during total in vitro ischemia in canine heart. Circ Res 60:478-486.
279. Steenbergen C, Murphy E, Watts JA, and London RE (1990). Correlation between cytosolic free calcium, contracture, ATP, and irreversible ischemic injury in perfused rat heart. Circ Res 66:135-146.
280. Stein B, Frank P, Schmitz W, Scholz H, and Thoenes M (1996). Endotoxin and cytokines induce direct cardiodepressive effects in mammalian cardiomyocytes via induction of nitric oxide synthase. J Mol Cell Cardiol 28:1631-1639.
281. Steller H (1995). Mechanisms and genes of cellular suicide. Science 267:1445-1448.
282. Sun J-Z, Tang X-L, Knowlton AA, Park SW, Qiu Y, and Bolli R (1995). Late preconditioning against myocardial stunning: An endogenous protective mechanism that confers resistance to postischemic dysfunction 24 h after brief ischemia in conscious pigs. J Clin Invest 95:388-403.
283. Sun J-Z, Tang X-L, Park SW, Qiu Y, Turrens JF, and Bolli R (1996). Evidence for an essential role of reactive oxygen species in the genesis of late preconditioning against myocardial stunning in conscious pigs. J Clin Invest 97:562-576.
284. Susin SA, Zamzami N, Castedo M, Daugas E, Wang H-G, Geley S, Fassy F, Reed JC, and Kroemer G (1997). The central executioner of apoptosis: Multiple connections between protease activation and mitochondria in Fas/APO-1/ CD95- and ceramide-induced apoptosis. J Exp Med 186:25-37.
285. Suzuki H, Wildhirt SM, Dudek RR, Narayan KS, Bailey AH, and Bing RJ (1996). Induction of apoptosis in myocardial infarction and its possible relationship to nitric oxide synthase in macrophages. Tissue Cell 28:89-97.
286. Szaboles M, Mickler RE, Yang X, Aji W, Roy D, Athan E, Sciacca RR, Minanov D, and Cannon PJ (1996). Apoptosis of cardiac myocytes during cardiac allograft rejection: Relation to induction of nitric oxide synthase. Circulation 94:1665-1673.
287. Takeda K, Yu Z-X, Nishikawa T, Tanaka M, Hosoda S, Ferrans VJ, and Kasajima T (1996). Apoptosis and DNA fragmentation in the bulbus cordis of the developing rat heart. J Mol Cell Cardiol 28:209-215.
288. Takemura G, Ohno M, Hayakawa Y, Misao J, Kanon M, Ohno A, Uno Y, Minatoguchi S, Fujiara T, and Fujiwara H (1998). Role of apoptosis in the disappearance of infiltrated and proliferated interstitial cells after myocardial infarction. Circ Res 82:1130-1138.
289. Tanaka M, Fujiwara H, Yamasaki K, Miyamae M, Yokota R, Hasegawa K, Fujiwara T, and Sasayama S (1994a). Ischemic preconditioning elevates cardiac stress protein but does not limit infarct size 24 or 48 h later in rabbits. Am J Physiol 267:H1476-1482.
290. Tanaka M, Ito H, Adachi S, Akimoto H, Nishikawa T, Kasajima T, Marumo F, and Hiroe M (1994b). Hypoxia induces apoptosis with enhanced expression of Fas antigen messenger RNA in cultured neonatal rat cardiomyocytes. Circ Res 75:426-433.
291. Tang X-L, Park SW, Qiu Y, Turrens JF, and Bolli R (1996). Time course of late preconditioning against myocardial stunning in conscious pigs. Circ Res 79:424-434.
292. Tang XL, Qiu Y, Turrens JF, Sun JZ, and Bolli R (1997). Late preconditioning against stunning is not mediated by increased antioxidant defenses in conscious pigs. Am J Physiol 273(4 Pt 2):H1651-H1657.
293. Taylor AL, Golino P, Eckels R, Pastor P, Buja LM, and Willerson JT (1990). Differential enhancement of postischemic segmental systolic thickening by diltiazem. J Am Coll Cardiol 15:737-747.
294. Teiger E, Than VD, Richard L, Wisnewsky C, Tea BS, Gaboury L, Tremblay J, Schwartz K, and Harnet P (1996). Apoptosis in pressure overload-induced heart hypertrophy in the rat. J Clin Invest 97:2891-2897.
295. Thandroyen FT, Bellotto D, Katayama A, Hagler HK, Willerson JT, and Buja LM (1992). Subcellular electrolyte alterations during progressive hypoxia and following reoxygenation in isolated neonatal rat ventricular myocytes. Circ Res 71:106-119.
296. Thandroyen FT, Morris AC, Hagler HK, Ziman B, Pai L, Willerson JT, and Buja LM (1991). Intracellular calcium transients and arrhythmias in isolated cells. Circ Res 69:810-819.
297. Thandroyen FT, Muntz KH, Buja LM, and Willerson JT (1990). Alterations in beta-adrenergic receptors, adenylate cyclase, and cyclic AMP concentration during acute myocardial ischemia and reperfusion. Circulation 82(Suppl II):HH30-HH37.
298. Thompson CB (1995). Apoptosis in the pathogenesis and treatment of disease. Science 267:1456-1461.
299. Tsao PS, Aoki N, Lefer DJ, Johnson G III, and Lefer AM (1990). Time course of endothelial dysfunction and myocardial injury during myocardial ischemia and reperfusion in the cat. Circulation 82:1402-1412.
300. Uhl HSM (1996). Uhl's anomaly revisited. Circulation 93: 1483-1484.
301. Urmansky SR, Cuenco GM, Khutzian SS, Barr PJ, and Tomei DC (1995). Post-ischemic apoptosis death of rat neonatal cardiomyocytes. Cell Death Diff 2:235-241.
302. Vakeva AP, Agah A, Rollins SA, Matis LA, Li L, and Stahl GL (1998). Myocardial infarction and apoptosis after myocardial ischemia and reperfusion: Role of the terminal complement components and inhibition by anti-C5 therapy. Circulation 97:2259-2267.
303. Valente M, Calabrese F, Thiene G, Angelini A, Basso C, Nava A, and Rossi L (1998). In vivo evidence of apoptosis in arrhythmogenic right ventricular cardiomyopathy. Am J Pathol 152:479-484.
304. Van Winkle WB, Snuggs M, and Buja LM (1995). Hypoxia-induced alterations in cytoskeleton coincide with collagenase expression in cultured neonatal rat cardiomyocytes. J Mol Cell Cardiol 27:2532-2542.
305. Vander Heide RS, Hill ML, Reimer KA, and Jennings RB (1996). Effect of reversible ischemia on the activity of the mitochondrial ATPase: Relationship to ischemic preconditioning. J Mol Cell Cardiol 28:103-112.
306. Vander Heide RS, Schwartz LM, Jennings RB, and Reimer KA (1995). Effect of catecholamine depletion on myocardial infarct size in dogs: Role of catecholamines in ischemic preconditioning. Cardiovasc Res 30:656-662.
307. Vanoverschelde J-LJ, Wijns W, Borgers M, Heyndrickx G, Depre C, Flameng W, and Melin JA (1997). Chronic myocardial hibernation in humans: From bedside to bench. Circulation 95:1961-1971.
308. 2 receptors. Br J Pharmacol 113:1167-1172.
309. Vegh A, Papp JG, Szekeres L, and Parratt JR (1993). Prevention by an inhibitor of the L-arginine-nitric oxide pathway of the antiarrhythmic effects of bradykinin in anaesthetized dogs. Br J Pharmacol 110:18-19.
310. Vegh A, Papp JG, Szekeres, and Parratt J (1992b). The local intracoronary administration of methylene blue prevents the pronounced antiarrhythmic effect of ischaemic preconditioning. Br J Pharmacol 107:910-911.
311. Vegh A, Szekeres L, and Parratt J (1992a). Preconditioning of the ischaemic myocardium; involvement of the L-arginine nitric oxide pathway. Br J Pharmacol 107:648-652.
312. Vermes I, Haanen C, Steffens-Nakken H, and Reutelingsperger C (1995). A novel assay for apoptosis: Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labeled Annexin V. J Immunol Methods 184:39-51.
313. Virmani R, Kolodgie FD, Forman MB, Farb A, and Jones RM (1992). Reperfusion injury in the ischemic myocardium. Cardiovasc Pathol 1:117-130.
314. Vogel WM, Apstein CS, Briggs LL, Gaasch WH, and Ahn J (1982). Acute alterations in left ventricular diastolic chamber stiffness: Role of the "erectile" effect of coronary arterial pressure and flow in normal and damaged hearts. Circ Res 51:465-476.
315. Wang D, McMillin JB, Bick R, and Buja LM (1996). Response of the neonatal rat cardiomyocyte in culture to energy depletion: Effects of cytokines, nitric oxide, and heat shock proteins. Lab Invest 75:809-818.
316. Wang WZ, Matsumori A, Yamada T, Shioi T, Okada I, Matsui S, Sato Y, Suzuki H, Shiota K, and Sasayama S (1997). Beneficial effects of amlodipine in a murine model of congestive heart failure induced by viral myocarditis: A possible mechanism through inhibition of nitric oxide production. Circulation 95:245-251.
317. Weisfeldt ML (1987). Reperfusion and reperfusion injury. Clin Res 35:13-20.
318. Weselcouch EO, Baird AJ, Sleph P, and Grover GJ (1995). Inhibition of nitric oxide synthesis does not affect ischemic preconditioning in isolated perfused rat hearts. Am J Physiol 268:H242-H249.
319. Weyrich AS, Ma X, and Lefer AM (1992). The role of L-arginine in ameliorating reperfusion injury after myocardial ischemia in the cat. Circulation 86:279-288.
320. Wijns W, Vatner SF, and Camici PG (1998). Hibernating myocardium. N Engl J Med 339:173-181.
321. Willerson JT and Buja LM (1984). Short- and long-term influence of the beta-adrenergic antagonists after acute myocardial infarction. Am J Cardiol 54(Suppl E):16E-20E.
322. Willerson JT, Parkey RW, Bonte FJ, Lewis SE, Corbett J, and Buja LM (1980). Pathophysiologic considerations and clinicopathological correlates of technetium-99 m stannous pyrophosphate myocardial scintigraphy. Semin Nuc Med 10: 54-69.
323. Willerson JT, Yao S-K, Ferguson JJ, Anderson HV, Golino P, and Buja LM (1991 a). Unstable angina pectoris and the progression to acute myocardial infarction: Role of platelets and platelet-derived mediators. Tex Heart Inst J 18:243-247.
324. Willerson JT, Yao S-K, McNatt J, Benedict CR, Anderson HV, Golino P, Murphree SS, and Buja LM (1991b). Frequency and severity of cyclic flow alteration and platelet aggregation predict the severity of neointimal proliferation following experimental coronary stenosis and endothelial injury. Proc Natl Acad Sci USA 88:10624-10628.
325. Williams RS and Benjamin IJ (1991). Stress proteins and cardiovascular disease. Mol Biol Med 8:197-206.
326. 11C-acetate and positron emission tomography: Threshold criteria of reversible dysfunction. Circulation 95:1417-1424.
327. Woolfson RG, Patel VC, Neild GH, and Yellon DM (1995). Inhibition of nitric oxide synthesis reduces infarct size by an adenosine-dependent mechanism. Circulation 91:1545-1551.
328. Wylie AH (1980). Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activity. Nature 284:555-556.
329. Wylie AH, Morris RG, Smith AL, and Dunlop D (1984). Chromatin cleavage in apoptosis: Association with condensed chromatin morphology and dependence on macromolecular synthesis. J Pathol 142:67-77.
330. Wyllie AH, Arenas MJ, Morris RG, Walker SW, and Evans G (1992). The apoptosis endonuclease and its regulation. Semin Immunol 4:381-387.
331. Yang J, Liu X, Bhalla K, Kim CN, Ibrado AM, Cai J, Peng T-I, Jones DP, and Wang X (1997). Prevention of apoptosis by bcl-2: Release of cytochrome c from mitochondria blocked. Science 275:1129-1132.
332. Yang XM, Baxter GF, Heads RJ, Yellon DM, Downey JM, and Cohen MV (1996). Infarct limitation of the second window of protection in a conscious rabbit model. Cardiovasc Res 31:777-783.
333. Yao SK, Ober JC, Krishnaswami A, Ferguson JJ, Anderson V, Golino P, Buja LM, and Willerson JT (1992). Endogenous nitric oxide protects against platelet aggregation and cyclic flow variations in stenosed and endothelium-injured arteries. Circulation 86:1302-1309.
334. Yao Z, Auchampach JA, Pieper GM, and Gross GJ (1993). Cardioprotective effects of monophosphoryl lipid A, a novel endotoxin analogue, in the dog. Cardiovasc Res 27:832-838.
335. Yao Z, Mizumura T, Mei DA, and Gross GJ (1997). KATP channels and memory of ischemic preconditioning in dogs: Synergism between adenosine and KATP channels. Am J Physiol 272(1 Pt 2):H334-H342.
336. Yaoita H, Ogawa K, Maehara K, and Maruyama Y (1998). Attenuation of ischemic/reperfusion injury in rats by a caspase inhibitor. Circulation 97:276-281.
337. Yeh ETH (1997). Life and death in the cardiovascular system. Circulation 95:782-786.
338. Yellon DM and Latchman DS (1992). Stress proteins and myocardial protection. J Mol Cell Cardiol 24:113-124.
339. Yin T, Sandhu G, Wolfgang CD, Burrier A, Webb RL, Rigel DF, Hai T, and Whelan J (1997). Tissue-specific pattern of stress kinase activation in ischemia/reperfused heart and kidney. J Biol Chem 272:19943-19950.
340. Yoshida K, Maaieh MM, Shipley JB, Doloresco M, Bernardo NL, Qian YZ, Elliott GT, and Kukreja RC (1996). Monophosphoryl lipid A induces pharmacologic "preconditioning" in rabbit hearts without concomitant expression of 70-kDa heat shock protein. Mol Cell Biochem 156:1-8.
341. Yue T-L, Ma X-L, Wang X, Romanic AM, Liu G-L, Louden C, Gu J-L, Kumar S, Poste G, Ruffolo RR Jr, and Feuerstein GZ (1998). Possible involvement of stress-activated protein kinase signaling pathway and Fas receptor expression in prevention of ischemia/reperfusion-induced cardiomyocyte apoptosis by carvedilol. Circ Res 82:166-174.
342. Zhang X, Xie YW, Nasjletti A, Xu X, Wolin MS, and Hintze TH (1997). ACE inhibitors promote nitric oxide accumulation to modulate myocardial oxygen consumption. Circulation 95: 176-182.
343. Zhou X, Zhai X, and Ashraf M (1996). Direct evidence that initial oxidative stress triggered by preconditioning contributes to second window of protection by endogenous antioxidant enzyme in myocytes. Circulation 93:1177-1184.
344. Zou H, Henzel WJ, Liu X, Lutschg A, and Wang X (1997). Apaf-1, a human protein homologous to C. elegans-4, participates in cytochrome c-dependent activation of caspase-3. Cell 90:405-413.
345. Zweier JL, Wang P, and Kuppusamy P (1995). Direct measurement of nitric oxide generation in the ischemic heart using electron paramagnetic resonance spectroscopy. J Biol Chem 270:304-307.